Pricing transparency

Parsing the Drug Supply Chain
Health+Benefits Parsing the Drug Supply Chain
Q&A with Eric Levin, CEO of Scripta Insights
April 27, 2020
The Power of the Payer
Health+Benefits The Power of the Payer
Experts say now’s the time for employers to use their leverage to fight mega-m...
April 1, 2020
PBGH Drug Formulary Study
Health+Benefits PBGH Drug Formulary Study
Q&A with Lauren Vela, Senior Director of Member Value, Pacific Business Group on...
March 1, 2020
What Prescription Drug Importation Could Mean for Brokers
Health+Benefits What Prescription Drug Importation Could Mean for Brokers
Q&A with David Shore, SVP, Enterprise Strategy & Risk Management at Borislow Ins...
August 14, 2019
Medicare Part B Drug Pricing to Mirror Foreign Prices?
Health+Benefits Medicare Part B Drug Pricing to Mirror Foreign Prices?
CMS released an advanced notice of proposed rulemaking—with the spring of 2019...
November 8, 2018
What Does the Removal of Pharmacy ‘Gag Clauses’ Mean for Consumers?
Health+Benefits What Does the Removal of Pharmacy ‘Gag Clauses’ Mean for Consumers?
The Senate passed The Patient Right to Know Drug Prices Act, which bans gag clau...
September 20, 2018
Cigna-Express Scripts Deal Gets the Green Light
Health+Benefits Cigna-Express Scripts Deal Gets the Green Light
Cigna’s acquisition of Express Scripts was approved by federal officials
September 20, 2018
Healthcare and Big Data at the State Level: All-Payer Claims Databases (APCDs)
Health+Benefits Healthcare and Big Data at the State Level: All-Payer Claims Databases (APCDs)
What do Colorado, Arkansas, Delaware and Virginia have in common? In the spirit ...
August 9, 2018
A Common Language
Health+Benefits A Common Language
Q&A with Rod Cruickshank, President & CEO of The Partners Group
October 30, 2017
How Money Talks
Health+Benefits How Money Talks
Big Pharma’s hold on Congress and hidden cost structure slams your clients and...
June 1, 2015